© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
April 09, 2021
Pharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.
April 08, 2021
Infectious Diseases Focus
Developing an antimicrobial stewardship program is arduous but valuable; commitment from leadership is the first step.
April 07, 2021
Empiric anti-MRSA therapy is an area of opportunity for antimicrobial stewardship in the treatment of CAP.
April 06, 2021
Guidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.
April 05, 2021
Modifications include high rates of neoadjuvant endocrine chemotherapy, genomic assay testing on core biopsies, and delays in planned surgeries.
April 01, 2021
Thoughtful application can reduce resistance and improve overall operations, if consistent steps are followed.
March 31, 2021
Clinical Care Focus
Early recognition and treatment, along with a coordinated approach and multidisciplinary team, are important to limit disease progression.
March 26, 2021
The pharmacy community has stepped up mightily to ensure this massive health care effort is successful.
March 25, 2021
Digital health products and solutions expand ways to guide prevention and treatment.
March 24, 2021
Technology is essential, but not all solutions meet every goal or offer the same capabilities.
March 02, 2021
From the Chairman
COVID-19 is fueling the expansion of treatment methods beyond medications to include digital therapeutics.